INSIGHTS ON CLINICAL TRIAL PARTNERING

• The Shift Toward Self-Administration And Integrated Supply Chains

  Adopt integrated, end-to-end clinical supply strategies that enable self-administered therapies, reduce patient burden, and accelerate clinical trial timelines while improving access and outcomes.

• 5 Outdated Practices Holding Back Modern Bioanalysis

  Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

• Enhancing Participant Payments: A New Approach

  Managing participant payments in clinical trials is a multifaceted challenge impacting participants, sites, and sponsors alike. Delve into the intricacies and numerous hurdles faced in this process.

• Optimizing Clinical Supply Flexibility With Demand-Led Strategies

  Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.

• Modernizing Clinical Trial Logistics To Deliver Value

  2/3/2026

  Explore how biopharma organizations can design and operate clinical supply systems that absorb complexity while maintaining control and consistency.

• How NeuroKit® Helps Avoid False Negatives in Early CNS Development

  7/30/2026

  Detecting subtle CNS effects early can reduce false negatives. Sensitive assessments strengthen confidence in pharmacodynamic signals and dose selection.

   

• A More Intuitive IRB Submission Experience

  7/21/2026

  Gain insight into a more intuitive IRB submission experience that can help reduce friction, improve transparency, and support today’s virtual research workflows.

• The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials

  5/9/2025

  Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

• Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech

  10/2/2025

  This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian cancer and ensure its timely completion.